Pazopanib Hydrochloride With or Without Bicalutamide in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy

Conditions:   Hormone-Resistant Prostate Cancer;   Recurrent Prostate CarcinomaInterventions:   Drug: Bicalutamide;   Drug: Pazopanib Hydrochloride;   Other: Pharmacological Study;   Other: Laboratory Biomarker AnalysisSponsor:   National Cancer Institute (NCI)Active, not recruiting - verified July 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials